ArticleJCI insight2022

Pathological MAPK activation-mediated lymphatic basement membrane disruption causes lymphangiectasia that is treatable with ravoxertinib.

Harish P Janardhan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.